BioSpace2 小时
Sarepta, Biotech’s Regulatory Go-Getter, Signs Standout Rare Disease Deal
Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead ...
东方财富网2 小时
GSK超10亿美元“扫货”映恩生物 ADC领域下一步趋势如何？
12月4日，Duality ...